LINCOLN, Neb. (KOLN) — The Nebraska Legislature voted unanimously Tuesday to advance a bill requiring the Department of Health and Human Services to provide transparency in its assessment results for ...

ROANOKE, Va. (WDBJ) - With testing season rapidly approaching across Virginia, many students are feeling the pressure. From SOL exams in K-12 classrooms to AP, SAT, and ACT exams for high school ...

Starbucks is recognizing that its high-volume licensed locations in places like airports and college campuses don’t always provide the quickest, easiest experience. In a blog post on the company’s ...

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT owner looks to strengthen its portfolio against ‌rival Anthropic and gain more share in the ...

I am endlessly fascinated by the way home cooks set up their kitchens. From the condiments that line fridge doors, to the spices arranged in drawers or (gasp!) buried rows deep in cabinets, our ...

With a major change to the state's annual standardized assessment tests starting next week, some New Jersey school district leaders are frustrated by how slowly information on the change was released ...

Grubhub will test drone delivery of takeout orders for the first time, marking the latest effort from the company to experiment with automation technologies. The limited three-month pilot program, ...

LinkedIn made some good moves last year that I’ve seen pay off for our suite of B2B clients. Now that we’re into 2026, with yearly marketing goals in focus, I’ve got some recommendations based on our ...

GRAIL IS AN American biotech company with an ambitious goal: to develop a blood test for the early detection of over 50 types of cancer. It will not be easy. On February 19th the company announced ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience.View full ...

Feb 20 (Reuters) - Grail's (GRAL.O), opens new tab shares plunged nearly 50% on Friday after the company said routine screening with its cancer blood test failed to significantly boost early detection ...